Filtros : "ISPOR Europe" Limpar

Filtros



Refine with date range


  • Source: Value in Health. Conference titles: ISPOR Europe. Unidade: FCF

    Subjects: DOENÇAS RARAS, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BIGLIA, Luiza Vasconcelos et al. Expert validation on proposed framework for differentiated HTA criteria for rare disease drugs in Brazil. Value in Health. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.jval.2023.09.1783. Acesso em: 07 jun. 2024. , 2023
    • APA

      Biglia, L. V., Felippini, A., Ribeiro, T. B., Lima, T. D. M., & Aguiar, P. M. (2023). Expert validation on proposed framework for differentiated HTA criteria for rare disease drugs in Brazil. Value in Health. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1016/j.jval.2023.09.1783
    • NLM

      Biglia LV, Felippini A, Ribeiro TB, Lima TDM, Aguiar PM. Expert validation on proposed framework for differentiated HTA criteria for rare disease drugs in Brazil [Internet]. Value in Health. 2023 ; 26( 12): S337.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1016/j.jval.2023.09.1783
    • Vancouver

      Biglia LV, Felippini A, Ribeiro TB, Lima TDM, Aguiar PM. Expert validation on proposed framework for differentiated HTA criteria for rare disease drugs in Brazil [Internet]. Value in Health. 2023 ; 26( 12): S337.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1016/j.jval.2023.09.1783
  • Source: Posters. Conference titles: ISPOR Europe. Unidades: FCF, EE

    Assunto: SERVIÇOS FARMACÊUTICOS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RIBEIRO, A et al. Drugs involved in lawsuits filed against the Unified Health System (SUS) in São Paulo - Brazil, in 2017. 2018, Anais.. Barcelona: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, 2018. . Acesso em: 07 jun. 2024.
    • APA

      Ribeiro, A., Ribeiro, E., Nobre, M. R. C., & Secoli, S. R. (2018). Drugs involved in lawsuits filed against the Unified Health System (SUS) in São Paulo - Brazil, in 2017. In Posters. Barcelona: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
    • NLM

      Ribeiro A, Ribeiro E, Nobre MRC, Secoli SR. Drugs involved in lawsuits filed against the Unified Health System (SUS) in São Paulo - Brazil, in 2017. Posters. 2018 ;[citado 2024 jun. 07 ]
    • Vancouver

      Ribeiro A, Ribeiro E, Nobre MRC, Secoli SR. Drugs involved in lawsuits filed against the Unified Health System (SUS) in São Paulo - Brazil, in 2017. Posters. 2018 ;[citado 2024 jun. 07 ]
  • Source: Posters. Conference titles: ISPOR Europe. Unidades: FCF, EE

    Assunto: SERVIÇOS FARMACÊUTICOS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RIBEIRO, A et al. Serious adverse reactions reported for drugs involved in lawsuits filed against the Brazilian Public Health System. 2018, Anais.. Barcelona: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, 2018. . Acesso em: 07 jun. 2024.
    • APA

      Ribeiro, A., Ribeiro, E., Nobre, M. R. C., & Secoli, S. R. (2018). Serious adverse reactions reported for drugs involved in lawsuits filed against the Brazilian Public Health System. In Posters. Barcelona: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
    • NLM

      Ribeiro A, Ribeiro E, Nobre MRC, Secoli SR. Serious adverse reactions reported for drugs involved in lawsuits filed against the Brazilian Public Health System. Posters. 2018 ;[citado 2024 jun. 07 ]
    • Vancouver

      Ribeiro A, Ribeiro E, Nobre MRC, Secoli SR. Serious adverse reactions reported for drugs involved in lawsuits filed against the Brazilian Public Health System. Posters. 2018 ;[citado 2024 jun. 07 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024